Company news
Adhera Therapeutics Inc. news in 2022
Adhera Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.
Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist
September 19, 2022
Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin
July 19, 2022
Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ
May 19, 2022
Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board
March 21, 2022
Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace
January 20, 2022